NCT02663518 2024-05-10A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid TumorsPfizerPhase 1 Terminated249 enrolled 43 charts
NCT02960646 2023-02-16Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesM.D. Anderson Cancer CenterPhase 1 Completed11 enrolled
NCT00080925 2012-03-08T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed20 enrolled